Alicia Buck

5PUBLICATIONS
60CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 18, 2025
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models.

Miaomiao Sun, Maciej Bialasek, Maud Mayoux

|Nov 09, 2024
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker.

Tomás A Martins, Deniz Kaymak, Nazanin Tatari

|May 17, 2024
A prognostic neural epigenetic signature in high-grade glioma.

Richard Drexler, Robin Khatri, Thomas Sauvigny

|Jul 19, 2023
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.

Philip Schmassmann, Julien Roux, Alicia Buck

|Oct 20, 2019
DPI Selectively Inhibits Intracellular NADPH Oxidase Activity in Human Neutrophils.

Alicia Buck, Felix P Sanchez Klose, Vignesh Venkatakrishnan

Pageof 1

Frequent Collaborators

4 joint publications

Tobias Weiss

4 joint publications

Berend Snijder

3 joint publications

Gregor Hutter

3 joint publications

Michael Weller